Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France

J Infect Dis. 2010 Jul 15;202(2):247-50. doi: 10.1086/653583.

Abstract

In France, there have been variations in the incidence of invasive meningococcal infection due to serogroup C isolates. Infection peaks were observed in 1992 and 2003 that involved isolates of phenotypes C:2a:P1.5,2 and/or C:2a:P1.5, which belong to the sequence type 11 (ST-11) clonal complex. We report an emergence of isolates belonging to the ST-11 clonal complex since 2003. These isolates displayed a new phenotype, C:2a:P1.7,1, caused infections that occurred as clusters, and were associated with increased infection severity and high virulence in mice. These isolates may be responsible for a peak in the incidence of serogroup C meningococcal infection in France, for which there is no routine vaccination to date.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Vaccines / therapeutic use
  • Colony-Forming Units Assay
  • Disease Models, Animal
  • Disease Outbreaks / statistics & numerical data
  • Enzyme-Linked Immunosorbent Assay
  • France / epidemiology
  • Humans
  • Meningitis, Meningococcal / epidemiology*
  • Meningitis, Meningococcal / immunology
  • Meningococcal Infections / epidemiology*
  • Mice
  • Mice, Transgenic
  • Neisseria meningitidis / classification
  • Neisseria meningitidis / genetics*
  • Neisseria meningitidis / isolation & purification
  • Neisseria meningitidis / pathogenicity*
  • Phenotype
  • Transferrin / genetics

Substances

  • Bacterial Vaccines
  • Transferrin